Dasatinib 50mg Tablets

Dasatinib 50mg is a BCR-ABL tyrosine-kinase inhibitor used for selected Philadelphia-chromosome-positive leukaemias, including chronic myeloid leukaemia. Disease phase, prior treatment and molecular findings guide its use.
Take the tablet with or without food and swallow it whole. Avoid proton-pump inhibitors and H2 blockers; separate ordinary antacids by at least two hours before or after the dose.
Inhibition of BCR-ABL and selected other kinases interrupts signalling that drives proliferation of susceptible leukaemic cells.
Low blood counts, diarrhoea, headache, rash and fluid retention may occur.
Monitor blood counts and respiratory symptoms. Pleural effusion, pulmonary arterial hypertension, serious bleeding and QT effects need attention; grapefruit and strong CYP3A4 interactions can alter exposure.
Targets the abnormal kinase driver in susceptible leukaemia and supports haematological and molecular disease control.
They track BCR-ABL response more precisely than symptoms alone.
Yes. Proton-pump inhibitors and H2 blockers reduce absorption and should be reviewed.
Yes. New cough or breathlessness needs prompt assessment for pleural effusion and other causes.
No. Swallow whole and avoid exposure to broken-tablet contents.
Yes. Low platelets and impaired platelet function can increase bleeding risk.
Yes. It can alter drug exposure through CYP3A4 interactions.
It can harm a fetus; contraception and pregnancy planning need oncology guidance.
Not on that basis alone. Any treatment-free strategy requires specialist eligibility and close molecular monitoring.
BCR-ABL: an abnormal fusion protein that drives certain leukaemias. Philadelphia chromosome: a chromosome rearrangement producing BCR-ABL. Pleural effusion: fluid around the lung.; AR: Dasatinib 50mg أقراص; FR: Dasatinib 50mg comprimés; PT: Dasatinib 50mg comprimidos; ES: Dasatinib 50mg comprimidos; RU: Dasatinib 50mg таблетки; ID: Dasatinib 50mg tablet; VI: Dasatinib 50mg viên nén; MS: Dasatinib 50mg tablet; TL: Dasatinib 50mg tableta; ZH-SG: Dasatinib 50mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Dasatinib 50mg Tablets under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Dasatinib 50mg Tablets